397 related articles for article (PubMed ID: 11489822)
21. Identification of genes that are regulated transcriptionally by Myc in childhood tumors.
Raetz EA; Kim MK; Moos P; Carlson M; Bruggers C; Hooper DK; Foot L; Liu T; Seeger R; Carroll WL
Cancer; 2003 Aug; 98(4):841-53. PubMed ID: 12910530
[TBL] [Abstract][Full Text] [Related]
22. High microvessel density in primitive neuroectodermal brain tumors of childhood.
Grotzer MA; Wiewrodt R; Janss AJ; Zhao H; Cnaan A; Sutton LN; Rorke LB; Phillips PC
Neuropediatrics; 2001 Apr; 32(2):75-9. PubMed ID: 11414647
[TBL] [Abstract][Full Text] [Related]
23. Angiogenic profile of childhood primitive neuroectodermal brain tumours/medulloblastomas.
Huber H; Eggert A; Janss AJ; Wiewrodt R; Zhao H; Sutton LN; Rorke LB; Phillips PC; Grotzer MA
Eur J Cancer; 2001 Nov; 37(16):2064-72. PubMed ID: 11597385
[TBL] [Abstract][Full Text] [Related]
24. Histopathological and molecular prognostic markers in medulloblastoma: c-myc, N-myc, TrkC, and anaplasia.
Eberhart CG; Kratz J; Wang Y; Summers K; Stearns D; Cohen K; Dang CV; Burger PC
J Neuropathol Exp Neurol; 2004 May; 63(5):441-9. PubMed ID: 15198123
[TBL] [Abstract][Full Text] [Related]
25. Glial differentiation predicts poor clinical outcome in primitive neuroectodermal brain tumors.
Janss AJ; Yachnis AT; Silber JH; Trojanowski JQ; Lee VM; Sutton LN; Perilongo G; Rorke LB; Phillips PC
Ann Neurol; 1996 Apr; 39(4):481-9. PubMed ID: 8619526
[TBL] [Abstract][Full Text] [Related]
26. Tumorigenicity of cerebellar primitive neuro-ectodermal tumors in athymic mice correlates with poor prognosis in children.
Vassal G; Terrier-Lacombe MJ; Lellouch-Tubiana A; Valery CA; Sainte-Rose C; Morizet J; Ardouin P; Riou G; Kalifa C; Gouyette A
Int J Cancer; 1996 Apr; 69(2):146-51. PubMed ID: 8608984
[TBL] [Abstract][Full Text] [Related]
27. Hypofractionated stereotactic radiotherapy in the management of recurrent or residual medulloblastoma/PNET.
Saran F; Baumert BG; Creak AL; Warrington AP; Ashley S; Traish D; Brada M
Pediatr Blood Cancer; 2008 Mar; 50(3):554-60. PubMed ID: 17941071
[TBL] [Abstract][Full Text] [Related]
28. Aberrant promoter methylation of previously unidentified target genes is a common abnormality in medulloblastomas--implications for tumor biology and potential clinical utility.
Frühwald MC; O'Dorisio MS; Dai Z; Tanner SM; Balster DA; Gao X; Wright FA; Plass C
Oncogene; 2001 Aug; 20(36):5033-42. PubMed ID: 11526488
[TBL] [Abstract][Full Text] [Related]
29. Differential expression of survivin splice isoforms in medulloblastomas.
Li XN; Shu Q; Su JM; Adesina AM; Wong KK; Perlaky L; Antalffy BA; Blaney SM; Lau CC
Neuropathol Appl Neurobiol; 2007 Feb; 33(1):67-76. PubMed ID: 17239009
[TBL] [Abstract][Full Text] [Related]
30. Expression of O⁶-methylguanine-DNA methyltransferase in childhood medulloblastoma.
Faoro D; von Bueren AO; Shalaby T; Sciuscio D; Hürlimann ML; Arnold L; Gerber NU; Haybaeck J; Mittelbronn M; Rutkowski S; Hegi M; Grotzer MA
J Neurooncol; 2011 May; 103(1):59-69. PubMed ID: 20820873
[TBL] [Abstract][Full Text] [Related]
31. Heparanase, TrkC and p75NTR: their functional involvement in human medulloblastoma cell invasion.
Sinnappah-Kang ND; Kaiser AJ; Blust BE; Mrak RE; Marchetti D
Int J Oncol; 2005 Sep; 27(3):617-26. PubMed ID: 16077909
[TBL] [Abstract][Full Text] [Related]
32. Gene aberrations in childhood brain tumors.
Kucerová H; Stejskalová E; Vícha A; Tichý M; Chánová M; Sumerauer D; Koutechký J; Eckschlager T
Folia Biol (Praha); 2000; 46(5):187-90. PubMed ID: 11055797
[TBL] [Abstract][Full Text] [Related]
33. [Risk stratification in medulloblastoma: screening for molecular markers].
Ebinger M; Senf L; Scheurlen W
Klin Padiatr; 2006; 218(3):139-42. PubMed ID: 16688669
[TBL] [Abstract][Full Text] [Related]
34. [Hypermethylation as a potential prognostic factor and a clue to a better understanding of the molecular pathogenesis of medulloblastoma--results of a genomewide methylation scan].
Frühwald MC; O'Dorisio MS; Smith L; Dai Z; Wright FA; Paulus W; Jürgens H; Plass C
Klin Padiatr; 2001; 213(4):197-203. PubMed ID: 11528554
[TBL] [Abstract][Full Text] [Related]
35. Anti-proliferative activity of the quassinoid NBT-272 in childhood medulloblastoma cells.
von Bueren AO; Shalaby T; Rajtarova J; Stearns D; Eberhart CG; Helson L; Arcaro A; Grotzer MA
BMC Cancer; 2007 Jan; 7():19. PubMed ID: 17254356
[TBL] [Abstract][Full Text] [Related]
36. Microvessel density and vascular endothelial growth factor expression as predictors of childrens' survival from cerebellar medulloblastoma.
Tural S; Gercek A; Konya D; Ozgen S; Toplamoglu H; Ozek MM
J Clin Neurosci; 2009 Sep; 16(9):1199-202. PubMed ID: 19524442
[TBL] [Abstract][Full Text] [Related]
37. Apurinic/apyrimidinic endonuclease activity is associated with response to radiation and chemotherapy in medulloblastoma and primitive neuroectodermal tumors.
Bobola MS; Finn LS; Ellenbogen RG; Geyer JR; Berger MS; Braga JM; Meade EH; Gross ME; Silber JR
Clin Cancer Res; 2005 Oct; 11(20):7405-14. PubMed ID: 16243814
[TBL] [Abstract][Full Text] [Related]
38. [Different hypermethylation status of RASSF1A in medulloblastoma and supratentorial primitive neuroectodermal tumor].
Chang Q; Ng HK
Zhonghua Bing Li Xue Za Zhi; 2007 Jan; 36(1):24-8. PubMed ID: 17374234
[TBL] [Abstract][Full Text] [Related]
39. A role for fluorescence in situ hybridization detection of chromosome 22q dosage in distinguishing atypical teratoid/rhabdoid tumors from medulloblastoma/central primitive neuroectodermal tumors.
Bruch LA; Hill DA; Cai DX; Levy BK; Dehner LP; Perry A
Hum Pathol; 2001 Feb; 32(2):156-62. PubMed ID: 11230702
[TBL] [Abstract][Full Text] [Related]
40. Medulloblastoma: presentation, diagnosis and management.
Packer RJ; Finlay JL
Oncology (Williston Park); 1988 Sep; 2(9):35-45, 48-9. PubMed ID: 3275066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
